Literature DB >> 21879775

Off-label pharmacovigilance.

I Ralph Edwards.   

Abstract

Mesh：

Year:  2011        PMID： 21879775     DOI： 10.2165/11596140-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  7 in total

1.  Labelling and 'Dear Doctor' letters: are they noncommittal?

Authors:  A C Kees van Grootheest; I Ralph Edwards
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Safety of recombinant activated factor VII in randomized clinical trials.

Authors:  Marcel Levi; Jerrold H Levy; Henning Friis Andersen; David Truloff
Journal:  N Engl J Med       Date:  2010-11-04       Impact factor: 91.245

3.  When off label is off target.

Authors: 
Journal:  Nat Med       Date:  2011-06       Impact factor: 53.440

4.  Postpartum purpura fulminans: successful management with streptokinase.

Authors:  F E Preston; I R Edwards
Journal:  Br Med J       Date:  1973-08-11

5.  Malaria with disseminated intravascular coagulation and peripheral tissue necrosis successfully treated with streptokinase.

Authors:  I R Edwards
Journal:  Br Med J       Date:  1980-05-24

Review 6.  An evaluation of eptacog alfa in nonhaemophiliac conditions.

Authors:  Gordon Mallarkey; Tim Brighton; Amanda Thomson; Karen Kaye; Paul Seale; Madlen Gazarian
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study.

Authors:  Werner Zenz; Bettina Zoehrer; Michael Levin; Sergio Fanconi; Tassos D Hatzis; Geoff Knight; Marcus Müllner; Saul N Faust
Journal:  Crit Care Med       Date:  2004-08       Impact factor: 7.598
  7 in total
  1 in total

1.  Preventive pharmacologic treatments for episodic migraine in adults.

Authors:  Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal:  J Gen Intern Med       Date:  2013-04-17       Impact factor: 5.128
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.